We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Groundbreaking Ultrasound-Guided Needle Insertion System Improves Medical Procedures

By HospiMedica International staff writers
Posted on 08 Oct 2024
Print article
Image: The advanced ultrasound-guided needle insertion system addresses key challenges in current procedural guidance (Photo courtesy of RIVANNA)
Image: The advanced ultrasound-guided needle insertion system addresses key challenges in current procedural guidance (Photo courtesy of RIVANNA)

Ultrasound-guided neuraxial procedures have traditionally been hampered by technical challenges, such as the need for three hands to manage the needle, probe, and syringe simultaneously, steep needle angles limiting ultrasound visibility, and difficulties in achieving real-time in-plane approaches with standard probes. Now, an advanced ultrasound-guided needle insertion system overcomes these obstacles by significantly enhancing the accuracy and safety of needle-based medical procedures.

RIVANNA (Charlottesville, VA, USA) has introduced an innovative ultrasound-guided needle insertion technology designed to enhance the precision and safety of procedures involving targeted needle insertion into organs, tumors, fluid collections, and blood vessels for biopsies, ablations, therapeutic injections, fluid aspirations, and catheter placements. The system features a dual-array multi-angle probe with ultrasound arrays uniquely arranged to transmit and receive angled sound waves that converge within the patient's anatomy, improving the needle's visibility. A detachable needle guide helps keep the needle aligned within the probe's optimal viewing planes, allowing for real-time visualization of the needle's path, and ensuring more accurate and reliable guidance. RIVANNA has been granted a patent for this technology, which effectively addresses the primary challenges of current procedural guidance systems.

Related Links:
RIVANNA

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Pediatric Phlebotomy Chair
2665M2 Extra Wide Pediatric Phlebotomy Chair
New
Rapid Cleaning Verification Tool
ProExpose Protein Detection Test

Print article

Channels

Critical Care

view channel
Image: The new technology can make heart-related predictions more widely accessible through the use of wearables (Photo courtesy of Fred Zwicky/UIUC)

Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery

The heart's response to physical activity is a vital early indicator of changes in health, particularly in cardiovascular function and mortality. Extensive research has demonstrated a connection between... Read more

Surgical Techniques

view channel
Image: The diffusion model was trained on real LGE-MRI distributions and generated synthetic fibrosis distributions from Gaussian noise (Photo courtesy of Frontiers, DOI: 10.3389/fcvm.2025.1512356)

AI-Generated Synthetic Scarred Hearts Aid Atrial Fibrillation Treatment

Atrial fibrillation (AF) is a common heart rhythm disorder, often linked to the development of fibrosis, which is the formation of scar tissue in the heart. This fibrosis typically arises due to aging,... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.